PERTUSSIS AND OTHER BORDETELLA INFECTIONS

Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition

Volumn , Issue , 2009, Pages 1683-1706

  Cherry, James D ^a,b   Heininger, Ulrich ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861171594     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4044-6.50145-X     Document Type: Chapter

References (433)

1. Ad Hoc Group for the Study of Pertussis Vaccines (1988) Placebo-controlled trial of two acellular pertussis vaccines in Sweden: Protective efficacy and adverse events. Lancet 1 955-960.
2. Advisory Panel of the Committee on Safety of Medicines (1981) The collection of data relating to adverse reactions in pertussis vaccine. Whooping Cough: Reports from the Committee on Safety of Medicines and the Joint Committee on Vaccination and Immunisation London: Department of Health and Social Security, Her Majesty's Stationery Office 27.
3. N. Aintablian, P. Walpita and M. Sawyer (1998) Detection of Bordetella pertussis and respiratory syncytial virus in air samples from hospital rooms. Infect. Control Hosp. Epidemiol. 19 918-923.
4. R. Alderslade, M.H. Bellman, N.S.B. Rawson, et al. (1981) The National Childhood Encephalopathy Study. Whooping Cough: Reports From the Committee on Safety of Medicines and the Joint Committee on Vaccination and Immunisation London: Department of Health and Social Security, Her Majesty's Stationery Office 79.
5. C. Amador, E. Chiner, J.L. Calpe, et al. (1991) Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Rev. Infect. Dis. 13 771-772.
6. American Academy of Pediatrics (2006) Active immunization: Pertussis. L.K. Pickering (Eds) 2006 Red Book: Report of the Committee on Infectious Diseases 25th ed. Elk Grove Village, IL: American Academy of Pediatrics 1-51. 498-520.
7. J.L. Arciniega, R.D. Shahin, W.N. Burnette, et al. (1991) Contribution of the B oligomer to the protective activity of genetically attenuated pertussis toxin. Infect. Immun. 59 3407-3410.
8. B. Arico and R. Rappuoli (1987) Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J. Bacteriol. 169 2847-2853.
9. J.C. Arnold, K.K. Singh, S.A. Spector, et al. (2006) Human bocavirus: Prevalence and clinical spectrum at a children's hospital. Clin. Infect. Dis. 43 283-288.
10. C.M. Ausiello, R. Lande, F. Urbani, et al. (2000) Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J. Infect. Dis. 181 1989-1995.
11. L.J. Baraff and J.D. Cherry (1979) Nature and rates of adverse reactions associated with pertussis immunization. C.R. Manclark, J.C. Hill (Eds) International Symposium on Pertussis. Publication No. (N. I. H.) 79-1830 Washington, D.C.: U.S. Dept. of Health, Education, and Welfare, U.S. Government Printing Office 291.
12. L.J. Baraff, C.R. Manclark, J.D. Cherry, et al. (1989) Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr. Infect. Dis. J. 8 502-507.
13. L.J. Baraff, C.L. Cody and J.D. Cherry (1984) DTP-associated reactions: An analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics 73 31-36.
14. L.J. Baraff, J. Wilkins and P.F. Wehrle (1978) The role of antibiotics, immunizations and adenoviruses in pertussis. Pediatrics 61 224-230.
15. W.E. Barlow, R.L. Davis, J.W. Glasser, et al. (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N. Engl. J. Med. 345 656-662.
16. S. Baron, E. Njamkepo, E. Grimprel, et al. (1998) Epidemiology of pertussis in French hospitals in 1993 and 1994: Thirty years after a routine use of vaccination. Pediatr. Infect. Dis. J. 17 412-418.
17. J.W. Bass (1985) Pertussis: Current status of prevention and treatment. Pediatr. Infect. Dis. J. 4 614-619.
18. J.W. Bass (1986) Erythromycin for treatment and prevention of pertussis. Pediatr. Infect. Dis. J. 5 154-157.
19. J.W. Bass, E.L. Klenk, J.B. Kotheimer, et al. (1969) Antimicrobial treatment of pertussis. J. Pediatr. 75 768-781.
20. A. Beiter, K. Lewis, E.F. Pineda, et al. (1993) Unrecognized maternal peripartum pertussis with subsequent fatal neonatal pertussis. Obstet. Gynecol. 82 691-693.
21. M.H. Bellman, E.M. Ross and D.L. Miller (1983) Infantile spasms and pertussis immunisation. Lancet 1 1031-1034.
22. J.M. Berg (1958) Neurological complications of pertussis immunization. Br. Med. J. 2 24.
23. S. Bergquist, S. Bernander, H. Dahnsjo, et al. (1987) Erythromycin in the treatment of pertussis: A study of bacteriologic and clinical effects. Pediatr. Infect. Dis. J. 6 458-461.
24. R. Bernales, J. Eastman and J. Kaplan (1976) Quantitation of circulating T and B lymphocytes in children with whooping cough. Pediatr. Res. 10 965-967.
25. Bhargava, A., Leininger, E., Roberts, M., et al.: Filamentous hemagglutinin and the 69-kDa protein, pertactin, promote adherence of Bordetella pertussis to epithelial cells and macrophages. Paper presented at the Sixth International Symposium on Pertussis, Bethesda, MD, September 26-28, 1990, pp. 137-138.
26. N.H. Birkebaek, M. Kristiansen, T. Seefeldt, et al. (1999) Bordetella pertussis and chronic cough in adults. Clin. Infect. Dis. 29 1239-1242.
27. K.M. Bisgard, F.B. Pascual, K.R. Ehresmann, et al. (2004) Infant pertussis: Who was the source? Pediatr. Infect. Dis. J. 23 985-989.
28. K.M. Bisgard, P. Rhodes, B.L. Connelly, et al. (2005) Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 116 e285-e294.
29. W.C. Blackwelder, J. Storsaeter, P. Olin, et al. (1991) Acellular pertussis vaccines. Am. J. Dis. Child. 145 1285-1289.
30. J. Bordet and O. Gengou (1906) Le microbe de la coqueluche. Ann. Inst. Pasteur (Paris) 20 48-68.
31. J. Bordet and O. Gengou (1909) L'endotoxin coquelucheuse. Ann. Inst. Pasteur (Paris) 23 415-419.
32. W.L. Bradford and B. Slavin (1937) An organism resembling Haemophilus pertussis with special reference to color changes produced by its growth upon certain media. Am. J. Public Health. 27 1277-1282.
33. M.J. Brennan, Z.M. Li, J.L. Cowell, et al. (1988) Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect. Immun. 56 3189-3195.
34. J. Broomhall and A. Herxheimer (1984) Treatment of whooping cough: The facts. Arch. Dis. Child. 59 185-187.
35. J.H. Brown (1926) Bacillus bronchisepticus infection in a child with symptoms of pertussis. Bull. Johns Hopkins Hosp. 38 147-153.
36. R.K. Byers and F.C. Moll (1948) Encephalopathies following prophylactic pertussis vaccine. Pediatrics 1 437-457.
37. J.M. Celermajor and J. Brown (1966) The neurological complications of pertussis. Med. J. Aust. 1 1066-1069.
38. Centers for Disease Control and Prevention (1999) Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin: Knoxville, Tennessee, 1999. M. M. W. R. Morb. Mortal. Wkly. Rep. 48 1117-1140.
39. Centers for Disease Control and Prevention (2002) Pertussis: United States, 1997-2000. M. M. W. R. Morb. Mortal. Wkly. Rep. 51 73-76.
40. Centers for Disease Control and Prevention (2004) Fatal case of unsuspected pertussis diagnosed from a blood culture: Minnesota, 2003. M. M. W. R. Morb. Mortal. Wkly. Rep. 53 131-132.
41. Centers for Disease Control and Prevention (2004) Summary of notifiable diseases: United States, 2004. M. M. W. R. Morb. Mortal. Wkly. Rep. 53 1-80.
42. Centers for Disease Control and Prevention (2005) Pertussis: United States, 2001-2003. M. M. W. R. Morb. Mortal. Wkly. Rep. 54 1283-1286.
43. Centers for Disease Control and Prevention (2005) Recommended antimicrobial agents for the treatment and postexposure prophylaxes of pertussis: 2005 CDC guidelines. M. M. W. R. Morb. Mortal. Wkly. Rep. 54 1-16.
44. Centers for Disease Control and Prevention (2006) Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. M. M. W. R. Morb. Mortal. Wkly. Rep. 55 1-33.
45. Centers for Disease Control and Prevention (2006) Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphetheria toxoid and acellular pertussis vaccines. M. M. W. R. Morb. Mortal. Wkly. Rep. 55 1-34.
46. R. Chaby and M. Caroff (1988) Lipopolysaccharides of Bordetella pertussis endotoxin. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 247-272.
47. A.P. Chakravorty (1963) Blindness after use of triple antigen. Br. Med. J. 1 105.
48. I.G. Charles, J.L. Li, M. Roberts, et al. (1991) Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis. Eur. J. Immunol. 21 1147-1153.
49. J.D. Cherry (1984) The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: A comparative study. Curr. Probl. Pediatr. 14 1-78.
50. J.D. Cherry (1989) Pertussis and the vaccine controversy. R.K. Root, J.M. Griffiss, K.S. Warren, et al., (Eds) Immunization New York: Churchill Livingstone 47-63.
51. J.D. Cherry (1990) Pertussis vaccine encephalopathy: It is time to recognize it as the myth that it is. JAMA 263 1679-1680.
52. J.D. Cherry (1992) Pertussis: The trials and tribulations of old and new pertussis vaccines. Vaccine 10 1033-1038.
53. J.D. Cherry (1993) Acellular pertussis vaccines: A solution to the pertussis problem. J. Infect. Dis. 168 21-24.
54. Cherry, J. D.: Strategies for Diphtheria, Tetanus, and Pertussis (DTP) Immunization: Report of the 104th Ross Conference on Pediatric Research. Columbus, OH, Ross Products Division, Abbott Laboratories, 1994, pp. 218-225.
55. J.D. Cherry (1996) Historical review of pertussis and the classical vaccine. J. Infect. Dis. 174(Suppl.), 259-263.
56. J.D. Cherry (1997) Comparative efficacy of acellular pertussis vaccines: An analysis of recent trials. Pediatr. Infect. Dis. J. 16(Suppl.), 90-96.
57. J.D. Cherry (1999) Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin. Infect. Dis. 28(Suppl 2), 112-117.
58. J.D. Cherry (1999) Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin. Infect. Dis. 28(Suppl. 2), 107-111.
59. J.D. Cherry (2005) Pertussis vaccines for adolescents and adults. Pediatrics. 116 755-756.
60. J.D. Cherry (2005) The epidemiology of pertussis: A comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatr. Infect. Dis. J. 115 1422-1427.
61. J.D. Cherry (2006) Epidemiology of pertussis. Pediatr. Infect. Dis. J. 25 361-362.
62. J.D. Cherry (2007) Historical perspective on pertussis and use of vaccines to prevent it. Microbe 2 139-144.
63. Cherry, J. D.: Unpublished observation.
64. J.D. Cherry and E.A. Mortimer (1987) Acellular and whole-cell pertussis vaccines in Japan: Report of a visit by US scientists. JAMA 257 1375-1376.
65. J.D. Cherry and P. Olin (1999) Commentaries: The science and fiction of pertussis vaccines. Pediatrics 104 1381-1384.
66. J.D. Cherry, L.J. Baraff and E. Hewlett (1989) The past, present, and future of pertussis: The role of adults in epidemiology and future control. West. J. Med. 150 319-328.
67. J.D. Cherry, T. Beer, S.A. Chartrand, et al. (1995) Comparison of antibody values to Bordetella pertussis antigens in young German and American men. Clin. Infect. Dis. 20 1271-1274.
68. J.D. Cherry, P.A. Brunell, G.S. Golden, et al. (1988) Report of the Task Force on Pertussis and Pertussis Immunization: 1988. Pediatrics 81(Suppl.), 939-984.
69. J.D. Cherry, J. Gornbein, U. Heininger, et al. (1998) A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16 1901-1906.
70. Cherry, J.D., Grimprel, E., Guiso, N., et al: Defining pertussis epidemiology: Clinical, microbiologic and serologic perspectives. Pediatr. Infect. Dis. J. 24 (Suppl.):S25–S34–.
71. J.D. Cherry, U. Heininger, K. Stehr, et al. (1998) The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial. Pediatrics 102 909-912.
72. K.W. Choy, N.M. Wulffraat, T.F.W. Wolfs, et al. (1999) Bordetella bronchiseptica respiratory infection in a child after a bone marrow transplantation. Pediatr. Infect. Dis. J. 18 481-482.
73. C.D.C. Christie and R.S. Baltimore (1989) Pertussis in neonates. Am. J. Dis. Child. 143 1199-1202.
74. C.D.C. Christie, M.L. Marx, C.D. Marchant, et al. (1994) The 1993 epidemic of pertussis in Cincinnati: Resurgence of disease in a highly immunized population of children. N. Engl. J. Med. 331 16-21.
75. C.L. Cody, L.J. Baraff, J.D. Cherry, et al. (1981) Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 68 650-660.
76. A.M. Collier, J.T. Connor and W.R. Irving Jr. (1966) Generalized type 5 adenovirus infection associated with the pertussis syndrome. J. Pediatr. 69 1073-1978.
77. T.E. Cone Jr. (1970) Whooping cough is first described as a disease sui generis by Baillou in 1640. Pediatrics 46 522.
78. J.D. Connor (1970) Evidence for an etiological role of adenoviral infection in pertussis syndrome. N. Engl. J. Med. 283 390-394.
79. S.P. Conway, A.H. Balfour and H. Ross (1988) Serologic diagnosis of whooping cough by enzyme-linked immunosorbent assay. Pediatr. Infect. Dis. J. 7 570-574.
80. B.T. Cookson, P. Vandamme, L.C. Carlson, et al. (1994) Bacteremia caused by a novel Bordetella species, “ B. hinzii.” J. Clin. Microbiol. 32 2569-2571.
81. P.A. Cotter and J.F. Miller (2001) Bordetella. E.A. Groisman (Eds) Principles of Bacterial Pathogenesis San Diego: Academic Press 619-674.
82. J.L. Cowell, Y. Sato, H. Sato, et al. (1982) Separation, purification and properties of the filamentous hemagglutinin and the leukocytosis promoting factor-hemagglutinin from Bordetella pertussis. J.B. Robbins, J.C. Hill, G. Sadoff (Eds) Seminars in Infectious Disease. Vol. IV, Bacterial Vaccines: International Symposium on Bacterial Vaccines New York: Thieme-Stratton 371-379.
83. B.A. Cromer, J. Goydos, J. Hackell, et al. (1993) Unrecognized pertussis infection in adolescents. Am. J. Dis. Child. 147 575-577.
84. N.S. Crowcroft, N. Andrews, C. Rooney, et al. (2002) Deaths from pertussis are underestimated in England. Arch. Dis. Child. 86 336-338.
85. N.S. Crowcroft, R. Booy, T. Harrison, et al. (2003) Severe and unrecognised: Pertussis in UK infants. Arch. Dis. Child. 88 802-806.
86. D.R. Cundell, K. Kanthakumar, G.W. Taylor, et al. (1994) Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro. Infect. Immun. 62 639-643.
87. S.F. Davis, R.W. Sutter, P.M. Strebel, et al. (1995) Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: Clinical and epidemiological characteristics of illnesses manifested by cough. Clin. Infect. Dis. 20 621-628.
88. B.B. De Berry, J.E. Lynch, D.H. Chung, et al. (2005) Pertussis with severe pulmonary hypertension and leukocytosis treated with extracorporeal memebrane oxygenation. Pediatr. Surg. Int. 21 692-694.
89. G.R. Decker, J.P. Lavelle, P.N. Kuman, et al. (1991) Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Rev. Infect. Dis. 13 1250-1251.
90. M.D. Decker, K.M. Edwards, M.C. Steinhoff, et al. (1995) Comparison of 13 acellular pertussis vaccines: Adverse reactions. Pediatrics 96 557-566.
91. J.L. Deen, C.M. Mink, J.D. Cherry, et al. (1995) A household contact study of Bordetella pertussis infections in adults. Clin. Infect. Dis. 21 1211-1219.
92. H.E. De Melker, F.G.A. Versteegh, J.F.P. Schellekens, et al. (2006) The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J. Infect. 53 106-113.
93. G. De Serres, R. Shadmani, B. Duval, et al. (2000) Morbidity of pertussis in adolescents and adults. J. Infect. Dis. 182 174-179.
94. J.G. Deville, J.D. Cherry, P.D. Christenson, et al. (1995) Frequency of unrecognized Bordetella pertussis infections in adults. Clin. Infect. Dis. 21 639-642.
95. D.A. Diavatopoulos, C.A. Cummings, L.M. Schouls, et al. (2005) Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS. Pathog. 1 0373-0383.
96. A.F. Donoso, P.I. Cruces, J.F. Camacho, et al. (2006) Exchange transfusion to reverse severe pertussis-induced cardiogenic shock. Pediatr. Infect. Dis. J. 25 846-848.
97. A. Donoso, J. León, M. Ramírez, et al. (2005) Pertussis and fatal pulmonary hypertension: A discouraged entity. Scand. J. Infect. Dis. 37 145-148.
98. E. Douglas, J.G. Coote, R. Parton, et al. (1993) Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene. J. Med. Microbiol. 38 140-144.
99. M.S. Dworkin, P.S. Sullivan, S.E. Buskin, et al. (1999) Bordetella bronchiseptica infection in human immunodeficiency virus–infected patients. Clin. Infect. Dis. 28 1095-1099.
100. G. Edsall (1975) Present status of pertussis vaccination. Practitioner 215 310-314.
101. G. Edsall (1979) Comment. International Symposium on Pertussis, Bilthoven, 1969: Immunobiologic Standards 13 New York: S. Karger 170.
102. K.M. Edwards and M.D. Decker (2004) Pertussis vaccine. Vaccines 4 484-485.
103. G. Eldering and P. Kendrick (1952) Incidence of parapertussis in the Grand Rapids area as indicated by 16 years' experience with diagnostic cultures. Am. J. Public Health 42 27-31.
104. G. Eldering and P. Kendrick (1937) A group of cultures resembling both Bacillus pertussis and Bacillus bronchisepticus but identical with neither. J. Bacteriol. 33 71.
105. G. Eldering and P. Kendrick (1938) Bacillus parapertussis: A species resembling both Bacillus pertussis and Bacillus bronchiseptica but identical with neither. J. Bacteriol. 35 561-572.
106. G. Eldering, C. Hornbeck and J. Baker (1957) Serological study of Bordetella pertussis and related species. J. Bacteriol. 74 133-136.
107. E. Elliot, P. McIntyre, G. Ridley, et al. (2004) National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr. Infect. Dis. J. 23 246-252.
108. A. Erlandsson, A. Backman, M. Nygren, et al. (1998) Quantification of Bordetella pertussis in clinical samples by colorimetric detection of competitive PCR products. A. P. M. I. S. 106 1041-1048.
109. C.A. Ewanowich, L.W. Chui, M.G. Paranchych, et al. (1993) Major outbreaks of pertussis in northern Alberta, Canada: Analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J. Clin. Microbiol. 31 1715-1725.
110. K.M. Farizo, S.L. Cochi, E.R. Zell, et al. (1992) Epidemiological features of pertussis in the United States, 1980-1989. Clin. Infect. Dis. 14 708-719.
111. D.J. Farrell, M. McKeon, G. Daggard, et al. (2000) Rapid-cycle PCR method to detect Bordetella pertussis that fulfills all consensus recommendations for use of PCR in diagnosis of pertussis. J. Clin. Microbiol. 38 4499-4502.
112. Food and Drug Administration (2005) Product approval information-licensing action, package insert: BOOSTRIX. Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed. GlaxoSmithKline Biologicals Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research Available at http://www.fda.gov/cber/label/tdapgla122905LB.pdf.
113. Food and Drug Administration (2006) Product approval information-licensing action, package insert: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed ADACEL. Sanofi Pasteur Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research Available at http://www.fda.gov/cber/label/tdapave012306LB.pdf.
114. R.C. Fernandez and A.A. Weiss (1994) Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect. Immun. 62 4727-4738.
115. N.S. Ferry (1912) Bacillus bronchisepticus (bronchicanis): The cause of distemper in dogs and a similar disease in other animals. Vet. J. 68 376-391.
116. P.E.M. Fine (1988) Epidemiological considerations for whooping cough eradication. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 451-467.
117. P.E.M. Fine (1997) Implications of different study designs for the evaluation of acellular pertussis vaccines. Dev. Biol. Stand. 89 123-133.
118. P.E.M. Fine and J.A. Clarkson (1982) The recurrence of whooping cough: Possible implications for assessment of vaccine efficacy. Lancet 1 666-669.
119. P.E.M. Fine and J.A. Clarkson (1987) Reflections on the efficacy of pertussis vaccines. Rev. Infect. Dis. 9 866-883.
120. T.M. Finn and L.A. Stevens (1995) Tracheal colonization factor: A Bordetella pertussis secreted virulence determinant. Mol. Microbiol. 16 625-634.
121. W.H. Foege (May 7, 1982) Statement read before the Subcommittee on Investigations and General Oversight Committee on Labor and Human Resources Washington, D.C.: United States Senate
122. L.E. Friedman, M.T. Messina, L. Santoferrara, et al. (2006) Characterization of Bordetella bronchiseptica strains using phenotypic and genotypic markers. Vet. Microbiol. 117 313-320.
123. R.L. Friedman (1988) Pertussis: The disease and new diagnostic methods. Clin. Microbiol. Rev. 1 365-376.
124. G. Funke, T. Hess, A. von Graevenitz, et al. (1996) Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period. J. Clin. Microbiol. 34 966-969.
125. B.L. Furman, F.M. Sidey and M. Smith (1988) Metabolic disturbances produced by pertussis toxin. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 147-172.
126. J.L. Gale, P.B. Thapa, S.G.F. Wassilak, et al. (1994) Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine: A population-based case-control study. JAMA 271 37-41.
127. S. Gilberg, E. Njamkepo, I.P. Du Chatelet, et al. (2002) Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J. Infect. Dis. 186 415-418.
128. E.M. Glare, J.C. Paton, R.R. Premier, et al. (1990) Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J. Clin. Microbiol. 28 1982-1987.
129. A. Gil, I. Oyaguez, P. Carrasco, et al. (2001) Hospital admissions for pertussis in Spain, 1995-1998. Vaccine 19 4791-4794.
130. W.E. Goldman (1988) Tracheal cytotoxin of Bordetella pertussis. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 237-246.
131. Y.E. Goodman, A.J. Wort and F.L. Jackson (1981) Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection. J. Clin. Microbiol. 13 286-292.
132. R.A. Goodnow (1980) Biology of Bordetella bronchiseptica. Microbiol. Rev. 44 722-738.
133. J.E. Gordon and R.I. Hood (1951) Whooping cough and its epidemiological anomalies. Am. J. Med. Sci. 222 333-361.
134. M. Gordon, H.D. Davies and R. Gold (1994) Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period. Pediatr. Infect. Dis. J. 13 617-622.
135. G.D. Goulin, K.M. Kaya and J.S. Bradley (1993) Severe pulmonary hypertension associated with shock and death in infants infected with Bordetella pertussis. Crit. Care Med. 21 1791-1794.
136. G. Granström, P. Askelof and M. Granström (1988) Specific immunoglobulin A to Bordetella pertussis antigens in mucosal secretion for rapid diagnosis of whooping cough. J. Clin. Microbiol. 26 869-874.
137. M. Granström, A.A. Lindberg, P. Askelof and B. Hederstedt (1982) Detection of antibodies in human serum against fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay. J. Med. Microbiol. 15 85-96.
138. D. Greco, S. Salmaso, P. Mastrantonio, et al. (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334 341-348.
139. M.R. Griffin, W.A. Ray, J.R. Livengood, et al. (1988) Risk of sudden infant death syndrome after immunization with the diphtheria-tetanus-pertussis vaccine. N. Engl. J. Med. 319 618-623.
140. M.R. Griffin, W.A. Ray, E.A. Mortimer, et al. (1990) Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine. JAMA 263 1641-1645.
141. E. Grimpel, P. Begue, I. Anjak, et al. (1993) Comparison of polymerase chain reaction, culture and Western immunoblot serology for diagnosis of Bordetella pertussis infection. J. Clin. Microbiol. 31 2745-2750.
142. M.J. Grzeszczak, K.B. Churchwell, K.M. Edwards, et al. (2006) Leukapheresis therapy for severe infantile pertussis with myocardial and pulmonary failure. Pediatr. Crit. Care Med. 7 580-582.
143. P. Gueirard, C. Weber, A.L. Coustumier, et al. (1995) Human Bordetella bronchiseptica infection related to contact with infected animals: Persistence of bacteria in host. J. Clin. Microbiol. 33 2002-2006.
144. D. Güris, P.M. Strebel, B. Bardenheier, et al. (1999) Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. 28 1230-1237.
145. L. Gustafsson, H.O. Hallander, P. Olin, et al. (1996) A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334 349-355.
146. L. Gustafsson, L. Hessel, J. Storsaeter, et al. (2006) Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 118 978-984.
147. R. Hackman, D.G. Perrin, M. Karmali, et al. (1996) Fatal Bordetella pertussis infection: Report of two cases with novel pathologic findings. Pediatr. Pathol. 16 643-653.
148. N.B. Halasa, F.E. Barr, J.E. Johnson, et al. (2003) Fatal pulmonary hypertension associated with pertussis in infants: Does extracorporeal membrane oxygenation have a role? Pediatrics 112 1274-1278.
149. H.O. Hallander, J. Gnarpe, H. Gnarpe, et al. (1999) Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and persistent cough in children. Scand. J. Infect. Dis. 31 281-286.
150. H.O. Hallander, I. Reizenstein, B. Renemar, et al. (1993) Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J. Clin. Microbiol. 31 50-52.
151. H.O. Hallander, J. Storsaeter and R. Mollby (1991) Evaluation of serologic and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J. Infect. Dis. 163 1046-1054.
152. S.A. Halperin, R. Bortolussi, A. Kasina, et al. (1990) Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussis. J. Clin. Microbiol. 28 32-38.
153. S.A. Halperin, R. Bortolussi, J.M. Langley, et al. (1997) Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics 100 65-71.
154. S.A. Halperin, R. Bortolussi, D. MacLean, et al. (1989) Persistence of pertussis in an immunized population: Results of the Nova Scotia Enhanced Pertussis Surveillance Program. J. Pediatr. 115 686-693.
155. S.A. Halperin, B. Smith, M. Russell, et al. (2000) Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr. Infect. Dis. J. 19 276-283.
156. S.A. Halperin, E.E.L. Wang, B. Law, et al. (1999) Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: Report of the Immunization Monitoring Program-Active (IMPACT). Clin. Infect. Dis. 28 1238-1243.
157. J.H. Hannah, F.D. Menozzi, G. Renauld, et al. (1994) Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect. Immun. 62 5010-5019.
158. C.A. Hannik and H. Cohen (1979) Pertussis vaccine experience in the Netherlands. C.R. Manclark, J.C. Hill (Eds) International Symposium on Pertussis. Publication No. (N. I. H.) 79-1830 Washington, D.C.: U.S. Dept. of Health, Education, and Welfare, U.S. Government Printing Office 279.
159. R.A. Haward (1973) Scale of undernotification of infectious diseases by general practitioners. Lancet 1 873-874.
160. Q. He, J. Mertsola, H. Soini, et al. (1994) Sensitive and specific polymerase chain reaction assays for detection of Bordetella pertussis in nasopharyngeal specimens. J. Pediatr. 124 421-426.
161. S. Hedenskog, B. Bjorksten, M. Blennow, et al. (1989) Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine. Int. Arch. Allergy Appl. Immunol. 89 156-161.
162. U. Heininger (2001) Recent progress in clinical and basic pertussis research. Eur. J. Pediatr. 160 203-213.
163. U. Heininger and J.D. Cherry (2006) Pertussis immunization in adolescents and adults: Bordetella pertussis epidemiology should guide vaccination recommendations. Expert Opin. Biol. Ther. 6 1-13.
164. U. Heininger, J.D. Cherry, T. Eckhardt, et al. (1993) Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatr. Infect. Dis. J. 12 504-509.
165. Heininger, U., Cherry, J. D., Lugauer, S., et al.: Reactogenicity data following fourth and fifth doses of the Wyeth-Lederle Takeda acellular pertussis component vaccine: The Erlangen trial. Paper presented at the Acellular Pertussis Vaccine Conference, Bethesda, MD, November 12-14, 2000.
166. U. Heininger, J.D. Cherry, K. Stehr, et al. (1998) Comparative efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German infants following household exposure. Pediatrics 102 546-553.
167. U. Heininger, W.J. Kleemann, J.D. Cherry, et al. (2004) A controlled study of the relationship between Bordetella pertussis infection and sudden unexpected deaths in German infants. Pediatrics 114 e9-e15.
168. U. Heininger, K. Klich, K. Stehr, et al. (1997) Clinical findings in Bordetella pertussis infections: Results of a prospective multicenter surveillance study. Pediatrics 100 e10.
169. U. Heininger, G. Schläpfer, J.D. Cherry, et al. (2000) Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 105 e31.
170. U. Heininger, S. Schmitt-Grohè, J.D. Cherry, et al. (1995) Der Mikroagglutinationstest: Ein einfaches und sensitives Verfahren zur Serodiagnostik von Pertussis. Klin. Paediatr. 207 277-280.
171. U. Heininger, K. Stehr and J.D. Cherry (1992) Serious pertussis overlooked in infants. Eur. J. Pediatr. 151 342-343.
172. U. Heininger, K. Stehr, P. Christenson, et al. (1999) Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. Clin. Infect. Dis. 28 602-604.
173. U. Heininger, K. Stehr, G. Schläpfer, et al. (1996) Bordetella pertussis infections and sudden unexpected deaths in children. Eur. J. Pediatr. 155 551-553.
174. U. Heininger, K. Stehr, S. Schmitt-Grohè, et al. (1994) Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr. Infect. Dis. J. 13 306-309.
175. L.N. Heiss, J.R. Lancaster, J.A. Corbett, et al. (1994) Epithelial autotoxicity of nitric oxide: Role in the respiratory cytopathology of pertussis. Proc. Natl. Acad. Sci. U. S. A. 91 267-270.
176. S.M. Hellwig, M.E. Rodriguez, G.A. Berbers, et al. (2003) Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J. Infect. Dis. 188 738-742.
177. J. Henderson, K. North, M. Griffiths, et al. (1999) Pertussis vaccination and wheezing illnesses in young children: Prospective cohort study. BMJ 318 1173-1176.
178. P. Herzig, C. Hartmann, D. Fischer, et al. (1998) Pertussis complications in Germany: 3 years of hospital-based surveillance during the introduction of acellular vaccines. Infection 26 227-231.
179. E.L. Hewlett and J.D. Cherry (1990) New and improved vaccines against pertussis. G.C. Woodrow, M.M. Levine (Eds) New Generation Vaccines New York: Marcel Dekker 231-250.
180. E.L. Hewlett and J.D. Cherry (1997) New and improved vaccines against pertussis. M.M. Levine, G.C. Woodrow, J.B. Kaper, G.S. Cobon (Eds) New Generation Vaccines 2nd ed. New York: Marcel Dekker 387-416.
181. E.L. Hewlett and V.M. Gordon (1988) Adenylate cyclase toxin of Bordetella pertussis. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 193-209.
182. S.L. Hodder, J.D. Cherry, E.A. Mortimer, et al. (2000) Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin. Infect. Dis. 31 7-14.
183. H.J. Hoffman, J.C. Hunter, K. Damus, et al. (1987) Diphtheria-tetanus-pertussis immunization and sudden infant death: Results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome Risk Factors. Pediatrics 79 598-611.
184. W.H. Holmes (1940) Bacillary and Rickettsial Infections Acute and Chronic, a Textbook: Black Death to White Plague New York: Macmillan 395-414.
185. M.A. Honein, L.J. Paulozzi, I.M. Himelright, et al. (1999) Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: A case review and cohort study. Lancet 354 2101-2105.
186. J.E. Hoppe (1988) Methods for isolation of Bordetella pertussis from patients with whooping cough. Eur. J. Clin. Microbiol. Infect. Dis. 7 616-620.
187. J. Hoppe (1998) State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis. Infection 26 242-246.
188. J.E. Hoppe (1999) Update on respiratory infection caused by Bordetella parapertussis. Pediatr. Infect. Dis. J. 18 375-381.
189. J. Hoppe (2000) Neonatal pertussis. Pediatr. Infect. Dis. J. 19 244-247.
190. J. Hoppe and A. Eichhorn (1989) Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. Eur. J. Clin. Microbiol. Infect. Dis. 8 653-654.
191. J. Hoppe and A. Haug (1988) Antimicrobial susceptibility of Bordetella pertussis. Part I. Infection 16 126-130.
192. J. Hoppe, U. Halm, H. Hagedorn, et al. (1989) Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection 17 227-231.
193. S. Houard, C. Hackel, A. Herzog, et al. (1989) Specific identification of Bordetella pertussis by the polymerase chain reaction. Res. Microbiol. 140 477-484.
194. S.D. Hudnall and C.P. Molina (2000) Marked increase in L-selectin–negative T cells in neonatal pertussis: The lymphocytosis explained? Am. J. Clin. Pathol. 114 35-40.
195. T. Iida, A. Kunitani, Y. Komase, et al. (1983) Studies on experimental infection with Bordetella pertussis: Effect of cortisone on the infection and immunity in mice. Jpn. J. Exp. Med. 33 283-295.
196. L.I. Irons and A.R. Gorringe (1988) Pertussis toxin: Production, purification, molecular structure, and assay. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 95-120.
197. S. Iwata, T. Aoyama, H. Iwai, et al. (1991) Mixed outbreak of Bordetella pertussis and Bordetella parapertussis in an apartment house. Dev. Biol. Stand. 73 333-341.
198. F.E. Jackson (1963) Spontaneous spinal epidural hematoma coincident with whooping cough. J. Neurosurg. 20 715-717.
199. L.A. Jackson, B.A. Carste, D. Malais, et al. (2002) Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids. Pediatr. Inf. Dis. J. 21 781-785.
200. L.A. Jackson, J.D. Cherry, S.P. Wang, et al. (2000) Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin. Infect. Dis. 31 3-6.
201. W.M. Janda, E. Santos, J. Stevens, et al. (1994) Unexpected isolation of Bordetella pertussis from a blood culture. J. Clin. Microbiol. 32 2851-2853.
202. D.L. Jensen, G.C. Gray, S.D. Putnam, et al. (1997) Evaluation of pertussis in U.S. Marine Corps trainees. Clin. Infect. Dis. 25 1099-1107.
203. D. Jenkinson (1983) Whooping cough: What proportion of cases is notified in an epidemic? BMJ 287 183-185.
204. I.D. Johnston, D.P. Strachan, H.R. Anderson, et al. (1998) Effect of pneumonia and whooping cough in childhood on adult lung function. N. Engl. J. Med. 338 581-587.
205. Joint Committee on Vaccination and Immunisation: The whooping cough epidemic, 1977-79. In Whooping Cough: Reports from the Committee on Safety in Medicine and the Joint Committee on Vaccination and Immunisation. London, Department of Health and Social Security, Her Majesty's Stationery Office, 1981, pp. 170.
206. D.H. Jones, B.W. McBride, H. Jeffery, et al. (1995) Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae. Vaccine 13 675-681.
207. K. Kandola, A. Lea and M. Santos (2004) Pertussis rates in Northwest Territories after introducing adult formulation acellular vaccine. Can. J. Infect. Dis. Med. Microbiol. 15 351. Abstract.
208. W.A. Keitel, L.R. Muenz, M.D. Decker, et al. (1999) A randomized clinical trial of acellular pertussis vaccines in healthy adults: Dose-response comparisons of 5 vaccines and implications for booster immunization. J. Infect. Dis. 180 397-403.
209. P.L. Kendrick, G. Eldering, M.K. Dixon, et al. (1947) Mouse protection tests in the study of pertussis vaccines. Am. J. Public Health 37 803-810.
210. J.R. Kerr and R.C. Matthews (2000) Bordetella pertussis infection: Pathogenesis, diagnosis, management, and the role of protective immunity. Eur. J. Clin. Microbiol. Infect. Dis. 19 77-88.
211. K. Kersters, K.H. Hinz, A. Hertle, et al. (1984) Bordetella avium sp. nov., isolated from the respiratory tracts of turkeys and other birds. Int. J. Syst. Bacteriol. 34 56-70.
212. N. Khelef, H. Sakamoto and N. Guiso (1992) Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Microbiol. Pathog. 12 227-235.
213. M. Kimura and H. Kuno-Sakai (1988) Pertussis vaccines in Japan. Acta Paediatr. Jpn. 30 143-153.
214. A. Kimura, K.T. Mountzouros, D.A. Relman, et al. (1990) Bordetella pertussis filamentous hemagglutinin: Evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect. Immun. 58 7-16.
215. L. Knorr, J.D. Fox, P.A.G. Tilley, et al. (2006) Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection. BMC Infect. Dis. 6 1-12.
216. E.K. Korgenski and J.A. Daly (1997) Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States. J. Clin. Microbiol. 35 2989-2991.
217. F. Kowalzik, A. Barbosa, V.R. Fernandes, et al. (2007) Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr. Infect. Dis. 26 238-242.
218. M. Kulenkampff, J.S. Schwartzman and J. Wilson (1974) Neurological complications of pertussis inoculation. Arch. Dis. Child. 49 46.
219. T.L. Kurt, A.S. Yeager, S. Guenette, et al. (1972) Spread of pertussis by hospital staff. JAMA 221 264-267.
220. H.J. Lambert (1965) Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep 80 365-369.
221. J.H. Lapin (1943) Whooping Cough Springfield, IL: Charles C Thomas
222. H. Lautrop (1958) Observations on parapertussis in Denmark 1950-1957. Acta Pathol. Microbiol. Scand. 43 255-266.
223. N. Le Saux, N.J. Barrowman, D.L. Moore, et al. (2003) Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: A report from IMPACT. Pediatrics 112 348-353.
224. B. Lee (2000) Progressive respiratory distress in an infant treated for presumed pertussis. Pediatr. Infect. Dis. J. 19 475. 492-493
225. Leininger, E., Kenimer, J. G., and Brennan, M. J.: Surface proteins of Bordetella pertussis: Role in adherence. Paper presented at the Sixth International Symposium on Pertussis, Bethesda, MD, September 26-28, 1990, pp. 25-26.
226. K. Lewis, J.D. Cherry, M.H. Sachs, et al. (1988) The effect of prophylactic acetaminophen administration on reactions to DTP vaccination. Am. J. Dis. Child. 142 62-65.
227. K. Lewis, M.A. Saubolle, F.C. Tenover, et al. (1995) Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr. Infect. Dis. J. 14 388-391.
228. A.M. Li, D.L. Jansen, T.M. Finn, et al. (1994) Identification of Bordetella pertussis infection by shared-primer PCR. J. Clin. Microbiol. 32 783-789.
229. Z.M. Li, J.L. Cowell and M.J. Brennan (1988) Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect. Immun. 56 699-702.
230. R. Lichtinghagen, R. Diedrich-Glaubitz and B. von Hörsten (1994) Identification of B. pertussis in nasopharyngeal swabs using the polymerase chain reaction: Evaluation of detection methods. Eur. J. Clin. Chem. Clin. Biochem. 32 161-167.
231. J.G. Liese, C.K. Meschievitz, E. Harzer, et al. (1997) Efficacy of a two-component acellular pertussis vaccine in infants. Pediatr. Infect. Dis. J. 16 1038-1044.
232. L. Lind-Brandberg, C. Welinder-Olsson, T. Lagergard, et al. (1998) Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections. J. Clin. Microbiol. 36 679-683.
233. C. Lindgren, J. Milerad and H. Lagercrantz (1997) Sudden infant death and prevalence of whooping cough in the Swedish and Norwegian communities. Eur. J. Pediatr. 156 405-409.
234. S.W. Lindquist, D.J. Weber, M.E. Mangum, et al. (1995) Bordetella holmesii sepsis in an asplenic adolescent. Pediatr. Infect. Dis. J. 14 813-815.
235. C.C. Linnemann Jr. (1979) Host-parasite interactions in pertussis. C.R. Manclark, J.C. Hill (Eds) International Symposium on Pertussis. Publication No. (N. I. H.) 79-1830 Washington, D.C.: U.S. Dept. of Health, Education, and Welfare, U.S. Government Printing Office 3-18.
236. C.C. Linnemann Jr. and J. Nasenbeny (1977) Pertussis in the adult. Annu. Rev. Med. 28 179-185.
237. C.C. Linnemann Jr., N. Ramundo, P.H. Perlstein, et al. (1975) Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 2 540-543.
238. C. Locht, P. Bertin, F.D. Menozzi, et al. (1993) The filamentous haemagglutinin, a multifaceted adhesin produced by virulent Bordetella spp. Mol. Microbiol. 9 653-660.
239. M.J. Loeffelholz (2003) Bordetella. P.R. Murray, E.J. Baron, J.H. Jorgensen (Eds) Manual of Clinical Microbiology 8th ed. Washington, D.C.: American Society for Microbiology 780-788.
240. S. Long, H. Lischner, A. Deforest, et al. (1990) Serologic evidence of subclinical pertussis in immunized children. Pediatr. Infect. Dis. J. 9 700-705.
241. S. Long, C. Welkon and J. Clark (1990) Widespread silent transmission of pertussis in families: Antibody correlates of infection and symptomatology. J. Infect. Dis. 161 480-486.
242. S. Lugauer, U. Heininger, J.D. Cherry, et al. (2002) Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur. J. Pediatr. 161 142-146.
243. K.E. Luker, J.L. Collier, E.W. Kolodziej, et al. (1993) Bordetella pertussis tracheal cytotoxin and other muramyl peptides: Distinct structure-activity relationships for respiratory epithelial cytopathology. Proc. Natl. Acad. Sci. U. S. A. 90 2365-2369.
244. MacRae, K. D.: Epidemiology, encephalopathy, and pertussis vaccine. In FEMS-Symposium Pertussis: Proceedings of a Conference Organized by the Society of Microbiology and Epidemiology of the GDR. Berlin, April 20-22, 1988.
245. N. Madge, J. Diamond, D. Miller, et al. (1993) The national childhood encephalopathy study: A 10-year follow-up. Dev. Med. Child Neurol. 68(Suppl.), 1-119.
246. T. Madsen (1925) Whooping cough: Its bacteriology, diagnosis, prevention and treatment. Boston Med. Surg. J. 192 50-60.
247. B.P. Mahon, M.T. Brady and K.H.G. Mills (2000) Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: Implications for long-term immunity in children. J. Infect. Dis. 181 2087-2091.
248. A.M. Makhov, J.H. Hannah, M.J. Brennan, et al. (1994) Filamentous hemagglutinin of Bordetella pertussis: A bacterial adhesin formed as a 50-nm monomeric rigid rod based on a 19-residue repeat motif rich in beta strains and turns. J. Mol. Biol. 241 110-124.
249. F.B. Mallory and A.A. Hornor (1912) Pertussis: The histological lesion in the respiratory tract. J. Med. Res. 27 115-123.
250. C.R. Manclark, B.D. Meade and D.G. Burstyn (1986) Serological response to Bordetella pertussis. N.R. Rose, H. Friedman, J.L. Fahey (Eds) Manual of Clinical Laboratory Immunology 3rd ed. Washington, D.C.: American Society for Microbiology 388-394.
251. G. Mannerstedt (1934) Pertussis in adults. J. Pediatr. 5 596-600.
252. G.I. Martin and M.I. Weintraub (1973) Brachial neuritis and seventh nerve palsy: A rare hazard of DPT vaccination. Clin. Pediatr. (Phila.) 12 506-507.
253. P. Mastrantonio, P. Stefanelli and M. Giuliano (1996) Polymerase chain reaction for the detection of Bordetella pertussis in clinical nasopharyngeal aspirates. J. Med. Microbiol. 44 261-266.
254. P. Mastrantonio, P. Stefanelli and M. Giuliano (1998) Bordetella parapertussis infection in children: Epidemiology, clinical symptoms, and molecular characteristics of isolates. J. Clin. Microbiol. 36 999-1002.
255. H.R. Masure (1993) The adenylate cyclase toxin contributes to the survival of Bordetella pertussis within human macrophages. Microb. Pathog. 14 253-260.
256. P. Matherne, J. Matson and M.I. Marks (1986) Pertussis complicated by the syndrome of inappropriate antidiuretic hormone secretion. Clin. Pediatr. (Phila.) 25 46-48.
257. S. Mattoo and J.D. Cherry (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18 326-382.
258. E. Mazengia, E.A. Silva, J.A. Peppe, et al. (2000) Recovery of Bordetella holmesii from patients with pertussis-like symptoms: Use of pulsed-field gel electrophoresis to characterize circulating strains. J. Clin. Microbiol. 38 2330-2333.
259. J.A. McEniery, R.G. Delbridge and D.M. Reith (2004) Infant pertussis deaths and the management of cardiovascular compromise. J. Paediatr. Child Health 40 230-232.
260. J.P. McGowan (1911) Some observations on a laboratory epidemic, principally among dogs and cats, in which the animals affected presented the symptoms of the disease called “distemper.” J. Pathol. Bacteriol. 15 372-430.
261. J. McGregor, J. Ogle and G. Curry-Kane (1986) Perinatal pertussis. Obstet. Gynecol. 68 582-586.
262. B.D. Meade and A. Bollen (1994) Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J. Med. Microbiol. 41 51-55.
263. Medical Research Council (1951) The prevention of whooping cough by vaccination. Br. Med. J. 1 1463-1471.
264. Medical Research Council (1956) Vaccination against whooping cough: Relation between protection in children and results of laboratory tests. Br. Med. J. 2 454-462.
265. Medical Research Council (1959) Vaccination against whooping cough. Br. Med. J. 1 994-1000.
266. J.C. Melchior (1977) Infantile spasms and early immunization against whooping cough: Danish survey from 1970 to 1975. Arch. Dis. Child. 52 134.
267. J. Mertsola (1985) Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland. Eur. J. Clin. Microbiol. 4 123-128.
268. J. Mertsola, O. Ruuskanen, T. Kuronen, et al. (1990) Serologic diagnosis of pertussis: Evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J. Infect. Dis. 161 966-971.
269. L.K. Mikelova, S.A. Halperin, D. Scheifele, et al. (2003) Predictors of death in infants hospitalized with pertussis: A case-control study of 16 pertussis deaths in Canada. J. Pediatr. 143 576-581.
270. D. Miller, N. Madge, J. Diamond, et al. (1993) Pertussis immunisation and serious acute neurological illnesses in children. BMJ 307 1171-1176.
271. D. Miller, E.M. Ross, R. Alderslade, et al. (1981) Pertussis immunisation and serious acute neurological illness in children. BMJ 282 1595-1597.
272. D. Miller, J. Wadsworth, J. Diamond, et al. (1985) Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children. Dev. Biol. Stand. 61 389-394.
273. D. Miller, J. Wadsworth and E. Ross (1988) Severe neurological illness: Further analyses of the British National Childhood Encephalopathy Study. Tokai J. Exp. Clin. Med. 13(Suppl.), 145-155.
274. J.J. Miller Jr., R.J. Silverberg, T.M. Saito, et al. (1943) An agglutinative reaction for Hemophilus pertussis. II. Its relation to clinical immunity. J. Pediatr. 22 644-651.
275. K.H.G. Mills and K. Redhead (1993) Cellular immunity in pertussis. J. Med. Microbiol. 39 163-164.
276. K.H.G. Mills, A. Barnard, J. Watkins, et al. (1993) Cell-mediated immunity to Bordetella pertussis: Role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61 399-410.
277. N.N.T. Minh, Q. He, K. Edelman, et al. (1999) Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children. Pediatr. Infect. Dis. J. 18 366-370.
278. C. Mink, J.D. Cherry, P. Christenson, et al. (1992) A search for Bordetella pertussis infection in university students. Clin. Infect. Dis. 14 464-471.
279. C. Mink, C.H. O'Brien, S. Wassilak, et al. (1994) Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis. Infect. Immun. 62 1118-1120.
280. C. Mink, N.M. Sirota and S. Nugent (1994) Outbreak of pertussis in a fully immunized adolescent and adult population. Arch. Pediatr. Adolesc. Med. 148 153-157.
281. Mooi, F. A., van der Heide, H. G. J., Wellems, R., et al.: Bordetella pertussis fimbriae: Role in pathogenesis and mechanism of phase variation. Paper presented at the Sixth International Symposium on Pertussis, Bethesda, MD, September 26-28, 1990, pp. 63.
282. D.L. Moore, N. Le Saux, D. Scheifele, et al. (2004) Lack of evidence of encephalopathy related to pertussis vaccine: Active surveillance by IMPACT, Canada, 1993-2002. Pediatr. Infect. Dis. J. 23 568-571.
283. J.T. Morris and M. Myers (1998) Bacteremia due to Bordetella holmesii. Clin. Infect. Dis. 27 912-913.
284. W. Morrison (2007) Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Pediatr. Infect. Dis. J. 26 186-188.
285. E.A. Mortimer Jr. (1990) Pertussis and its prevention: A family affair. J. Infect. Dis. 161 473-479.
286. E.A. Mortimer Jr. and P.K. Jones (1979) An evaluation of pertussis vaccine. Rev. Infect. Dis. 1 927-932.
287. E.A. Mortimer Jr. and P.K. Jones (1979) Pertussis vaccine in the United States: The benefit-risk ratio. C.R. Manclark, J.C. Hill (Eds) International Symposium on Pertussis. Publication No. (N. I. H.) 79-1830 Washington, D.C.: U.S. Dept. of Health, Education, and Welfare, U.S. Government Printing Office 250.
288. E.A. Mortimer Jr., M. Kimura, J.D. Cherry, et al. (1990) Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children. Am. J. Dis. Child. 144 899-904.
289. K.T. Mountzouros, A. Kimura and J.L. Cowell (1992) A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis. Infect. Immun. 60 5316-5318.
290. F. Müller, J.E. Hoppe and C.H. Wirsing von König (1997) Laboratory diagnosis of pertussis: State of the art in 1997. J. Clin. Microbiol. 135 2435-2443.
291. J.J. Munoz (1988) Action of pertussigen (pertussis toxin) on the host immune system. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 173-192.
292. J. Nagel and E.J. Poot-Scholtens (1983) Serum IgA antibody to Bordetella pertussis as an indicator of infection. J. Med. Microbiol. 16 417-426.
293. Y. Nakase and M. Endoh (1988) Heat-labile toxin of Bordetella pertussis. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 217-229.
294. J.D. Nelson (1978) The changing epidemiology of pertussis in young infants: The role of adults as reservoirs of infection. Am. J. Dis. Child. 132 371-375.
295. K.E. Nelson, F. Gavitt, M.D. Batt, et al. (1975) The role of adenoviruses in the pertussis syndrome. J. Pediatr. 86 335-341.
296. L. Nencioni, M. Pizza, G. Volpini, et al. (1991) Properties of the B oligomer of pertussis toxin. Infect. Immun. 59 4732-4734.
297. M.E. Nennig, H.R. Shinefield, K.M. Edwards, et al. (1996) Prevalence and incidence of adult pertussis in an urban population. JAMA 275 1672-1674.
298. Newman, A., Davis, J. P., and Warshaner, D.: Personal communication. 2006.
299. V.L. Ng, J.M. Boggs, M.K. York, et al. (1992) Recovery of Bordetella bronchiseptica from patients with AIDS. Clin. Infect. Dis. 15 376-377.
300. A. Nicoll and A. Gardner (1988) Whooping cough and unrecognised postperinatal mortality. Arch. Dis. Child. 63 41-47.
301. G.R. Noble, R.H. Bernier, E.C. Esber, et al. (1987) Acellular and whole cell pertussis vaccines in Japan: Report of a visit by U. Scientists. SJAMA 257 1351-1356.
302. P. Novotny (1990) Pathogenesis in Bordetella species. J. Infect. Dis. 161 581-582.
303. P. Novotny, A.P. Chubb, K. Cownley, et al. (1991) Biologic and protective properties of the 69-kDa outer membrane protein of Bordetella pertussis: A novel formulation for an acellular pertussis vaccine. J. Infect. Dis. 164 114-122.
304. P. Olcen, A. Backman, B. Johansson, et al. (1992) Amplification of DNA by the polymerase chain reaction for the efficient diagnosis of pertussis. Scand. J. Infect. Dis. 24 339-345.
305. P. Olin, L. Gustafsson, L. Barreto, et al. (2003) Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine. 21 2015-2021.
306. P. Olin, F. Rasmussen, L. Gustafsson, et al. (1997) Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet 350 1569-1577.
307. L.C. Olsen (1975) Pertussis. Medicine (Baltimore) 54 427-469.
308. I.M. Onorato and S.G.F. Wassilak (1987) Laboratory diagnosis of pertussis: The state of the art. Pediatr. Infect. Dis. J. 6 145-151.
309. I.M. Onorato, S.G. Wassilak and B. Meade (1992) Efficacy of whole-cell pertussis vaccine in preschool children in the United States. JAMA 20 2745-2749.
310. Paddock, C. D., Cherry, J. D., Heininger, U. Unpublished data.
311. C.D. Paddock, G.N. Sanden, J.D. Cherry, et al. (2008) The pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin. Infect. Dis. J. 47 328-338.
312. J. Parkhill, M. Sebaihia, A. Preston, et al. (2003) Comparative analysis of the genome sequence of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35 32-40.
313. Pertussis (1983) Maryland, 1982. M. M. W. R. Morb. Mortal. Wkly. Rep. 32 297-300. 305
314. Pertussis surveillance, 1979-1981. M. M. W. R (1982) Morb. Mortal. Wkly. Rep. 31 333-336.
315. Pertussis (1984) United States, 1982 and 1983. M. M. W. R. Morb. Mortal. Wkly. Rep. 33 573-575.
316. M.E. Pichichero, K.M. Edwards, E.L. Anderson, et al. (2000) Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics 105 e11.
317. C. Pierce, N. Klein and M. Peters (2000) Is leukocytosis a predictor of mortality in severe pertussis infection? Intensive Care Med. 26 1512-1514.
318. V. Pillay and G. Swingler (2003) Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst. Rev. 4 CD003257.
319. M. Pittman (1979) Pertussis toxin: The cause of the harmful effects and prolonged immunity of whooping cough: A hypothesis. Rev. Infect. Dis. 1 401-412.
320. M. Pittman (1984) The concept of pertussis as a toxin-mediated disease. Pediatr. Infect. Dis. 3 467-486.
321. S. Pooboni, N. Roberts, C. Westrope, et al. (2003) Extracorporeal life support in pertussis. Pediatr. Pulmonol. 36 310-315.
322. J.F. Porter, K. Connor and W. Donachie (1994) Isolation and characterization of Bordetella parapertussis–like bacteria from ovine lungs. Microbiolology 140 255-261.
323. S. Postels-Multani, H.J. Schmitt, C.H. Wirsing von König, et al. (1995) Symptoms and complications of pertussis in adults. Infection 23 139-142.
324. A. Preston, J. Parkhill and D.J. Maskell (2004) The Bordetellae: Lessons from genomics. Nat. Rev. Microbiol. 2 379-390.
325. N.W. Preston (1988) Pertussis today. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 1-18.
326. H.E. Prince, M. Lapé-Nixon and J. Matud (2006) Evaluation of a Tetraplex Microsphere Assay for Bordetella pertussis antibodies. Clin. Vaccine Immunol. 13 266-270.
327. P. Ray, J. Hayward, D. Michelson, et al. (2006) Encephalopathy after whole-cell pertussis or measles vaccination. Pediatr. Infect. Dis. J. 25 768-773.
328. K.B. Register and G.N. Sanden (2006) Prevalence and sequence variants of IS 481 in Bordetella bronchiseptica: Implications for IS 481-based detection of Bordetella pertussis. J. Clin. Microbiol. 44 4577-4583.
329. E. Reizenstein, B. Johanson, L. Mardin, et al. (1993) Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis B. parapertussis, and B. bronchiseptica. Diagn. Microbiol. Infect. Dis. 17 185-191.
330. E. Reizenstein, L. Lindberg, R. Möllby, et al. (1996) Validation of nested Bordetella PCR in a pertussis vaccine trial. J. Clin. Microbiol. 34 810-815.
331. M.B. Rennels, M.A. Deloria, M.E. Pichichero, et al. (2000) Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 105 el2.
332. J.B. Robbins, M. Pittman, B. Trollfors, et al. (1993) Primum non nocere: A pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine. Pediatr. Infect. Dis. J. 12 795-807.
333. P.W. Robertson, H. Goldberg, B.H. Jarvie, et al. (1987) Bordetella pertussis infection: A cause of persistent cough in adults. Med. J. Aust. 146 522-525.
334. A. Robinson, L.A.E. Ashworth and L.I. Irons (1989) Serotyping Bordetella pertussis strains. Vaccine 7 491-494.
335. A. Robinson, L.I. Irons, R.N. Seabrook, et al. (1990) Structure-function studies of Bordetella pertussis fimbriae. C.R. Manclark (Eds) Proceedings of the Sixth International Symposium on Pertussis. D. H. H. S. Publication No. (F. D. A.) 90 Bethesda, MD: Department of Health and Human Services, U.S. Public Health Service 126-135.
336. M.E. Rodriguez, S.M.M. Hellwig, M.L.A.P. Vidakovics, et al. (2006) Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies. Immunol. Med. Microbiol. 46 39-47.
337. M.J. Romano, M.D. Weber, M.E. Weisse, et al. (2004) Pertussis pneumonia, hypoxemia, hyperleukocytosis, and pulmonary hypertension: improvement in oxygenation after a double volume exchange transfusion. Pediatrics 114 e264-e266.
338. S. Rosenthal, P. Strebel, P. Cassiday, et al. (1995) Pertussis infection among adults during the 1993 outbreak in Chicago. J. Infect. Dis. 171 1650-1652.
339. E.P. Rothstein, E.L. Anderson, M.D. Decker, et al. (1999) An acellular pertussis vaccine in healthy adults: Safety and immunogenicity. Pennridge Pediatric Associates. Vaccine 17 2999-3006.
340. M. Ryan, G. Murphy, L. Gothefors, et al. (1997) Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175 1246-1250.
341. M. Ryan, G. Murphy, E. Ryan, et al. (1998) Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93 1-10.
342. S. Salmaso, P. Mastrantonio, A.E. Tozzi, et al. (2001) Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: The Italian experience. Pediatrics 108 1-7.
343. S. Salmaso, P. Mastrantonio, S.G.F. Wassilak, et al. (1998) Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Vaccine 13 1270-1275.
344. M.B. Sans, J. Bonal, J. Bonet, et al. (1991) Bordetella bronchiseptica septicemia in a hemodialysis patient. Nephron 59 676.
345. H. Sato and Y. Sato (1984) Bordetella pertussis infection in mice: Correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system. Infect. Immun. 46 415-421.
346. Y. Sato, M. Kimura and H. Fukumi (1984) Development of a pertussis component vaccine in Japan. Lancet 1 122-126.
347. L.W. Sauer and L. Hambrecht (1929) Experimental whooping cough. Am. J. Dis. Child. 37 732-744.
348. G. Schläpfer, J.D. Cherry, U. Heininger, et al. (1995) Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatr. Infect. Dis. J. 14 209-214.
349. G. Schläpfer, H.P. Senn, R. Berger, et al. (1993) Use of the polymerase chain reaction to detect Bordetella pertussis in patients with mild or typical symptoms of infection. Eur. J. Clin. Microbiol. Infect. Dis. 12 459-463.
350. H.J. Schmitt, K. Beutel, A. Schuind, et al. (1997) Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age. J. Pediatr. 130 616-623.
351. H.J. Schmitt, C.H. Wirsing von König, A. Neiss, et al. (1996) Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275 37-41.
352. S. Schmitt-Grohè, J.D. Cherry, U. Heininger, et al. (1995) Pertussis in German adults. Clin. Infect. Dis. 27 860-866.
353. S. Schmitt-Grohè, K. Stehr, J.D. Cherry, et al. (1997) Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. Dev. Biol. Stand. 89 113-118.
354. R.D. Shahin, D.F. Amsbaugh and M.F. Leef (1992) Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection. Infect. Immun. 60 1482-1488.
355. R.D. Shahin, M.J. Brennan, B.D. Meade, et al. (1990) Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J. Exp. Med. 171 63-73.
356. W.D. Shields, C. Nielsen, D. Buch, et al. (1988) Relationship of pertussis immunization to the onset of neurologic disorders: A retrospective epidemiologic study. J. Pediatr. 113 801-805.
357. F. Simonond, M.P. Preziosi, A. Yam, et al. (1997) A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 15 1606-1612.
358. C. Smith and H. Vyas (2000) Early infantile pertussis: Increasingly prevalent and potentially fatal. Eur. J. Pediatr. 159 898-900.
359. D.P. Southall, M.G. Thomas and H.P. Lambert (1988) Severe hypoxaemia in pertussis. Arch. Dis. Child. 63 598-605.
360. C.D. Sreenan and H. Osiovich (2001) Neonatal pertussis requiring extracorporeal membrane oxygenation. Pediatr. Surg. Int. 17 201-203.
361. P. Stefanelli, P. Mastrantonio, S.Z. Hausman, et al. (1997) Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J. Clin. Microbiol. 35 1550-1555.
362. K. Stehr, J.D. Cherry, U. Heininger, et al. (1998) A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine or DT vaccine. Pediatrics 101 1-11.
363. R.W. Steketee, D.G. Burstyn, S.G.F. Wassilak, et al. (1988) A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J. Infect. Dis. 157 441-449.
364. R.W. Steketee, S.G.F. Wassilak, W.N. Adkins Jr., et al. (1988) Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J. Infect. Dis. 157 434-440.
365. J.B.P. Stephenson (1988) A neurologist looks at neurological disease temporally related to DTP immunization. Tokai J. Exp. Clin. Med. 13(Suppl.), 157-164.
366. G.T. Stewart (1977) Vaccination against whooping-cough: Efficacy versus risks. Lancet 1 234.
367. K.E. Stockbauer, B. Fuchslocher, J.F. Miller, et al. (2001) Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein. Mol. Microbiol. 39 65-78.
368. P. Stocks (1949) Studies in the Population of England and Wales 1944-47. Studies on Medical and Population Subjects. No. 2 London: His Majesty's Stationery Office
369. J. Storsaeter and P. Olin (1992) Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance. Vaccine 10 142-144.
370. J. Storsaeter, W.C. Blackwelder and H.O. Hallander (1992) Pertussis antibodies, protection, and vaccine efficacy after household exposure. Am. J. Dis. Child. 146 167-172.
371. J. Storsaeter, H. Hallander, C.P. Farrington, et al. (1990) Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine 8 457-461.
372. J. Storsaeter, H.O. Hallander, L. Gustafsson, et al. (1998) Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16 1907-1916.
373. P. Strebel, J. Nordin, K. Edwards, et al. (2001) Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J. Infect. Dis. 183 1353-1359.
374. P.M. Strebel, S.L. Cochi, K.M. Farizo, et al. (1993) Pertussis in Missouri: Evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Clin. Infect. Dis. 16 276-285.
375. J. Ström (1967) Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: A study based on vaccinations in Sweden 1959-65. Br. Med. J. 4 320.
376. Swansea Research Unit of the Royal College of General Practitioners (1987) Study of intellectual performance of children in ordinary schools after certain serious complications of whooping cough. BMJ 295 1044-1047.
377. W.P. Switzer, C.J. Mare and E.D. Hubbard (1966) Incidence of Bordetella bronchisepticum in wildlife and man in Iowa. Am. J. Vet. Res. 27 1134-1136.
378. F. Tamion, C. Girault, V. Chevron, et al. (1996) Bordetella bronchoseptica pneumonia with shock in an immunocompetent patient. Scand. J. Infect. Dis. 28 137-138.
379. M. Tanaka, C.R. Vitek, F.B. Pascual, et al. (2003) Trends in pertussis among infants in the United States, 1980-1999. JAMA 290 2968-2975.
380. Y.W. Tang, M.K. Hopkins, C.P. Kolbert, et al. (1998) Bordetella holmesii–like organisms associated with septicemia, endocarditis and respiratory failure. Clin. Infect. Dis. 26 389-392.
381. J. Taranger, B. Trollfors, T. Lagergard, et al. (1994) Parapertussis infection followed by pertussis infection. Lancet 2 1703.
382. J. Taranger, B. Trollfors, T. Lagergard, et al. (1997) Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants. Pediatr. Infect. Dis. J. 16 180-184.
383. P.F. Thomas, P.B. McIntyre and B.B. Jalaludin (2000) Survey of pertussis morbidity in adults in western Sydney. Med. J. Aust. 173 74-76.
384. T. Tomoda, H. Ogura and T. Kurashige (1991) Immune responses to Bordetella pertussis infection and vaccination. J. Infect. Dis. 163 559-563.
385. B. Trollfors, J. Taranger, T. Lagergard, et al. (1995) A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 333 1045-1050.
386. M. Troseid, T.O. Jonassen and M. Steinbakk (2006) Isolation of Bordetella pertussi in blood culture from a patient with multiple myeloma. J. Infect. 52 e11-e13.
387. E. Tuomanen (1988) Bordetella pertussis adhesins. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 75-94.
388. M.A. Überall, K. Stehr, J.D. Cherry, et al. (1997) Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. Dev. Biol. Stand. 89 83-89.
389. M. Ui (1988) The multiple biological activities of pertussis toxin. A.C. Wardlaw, R. Parton (Eds) Pathogenesis and Immunity in Pertussis New York: John Wiley & Sons 121-146.
390. A. Urisu, J.L. Cowell and C.R. Manclark (1986) Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect. Immun. 52 695-701.
391. Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series (2000) Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). M. M. W. R. Recomm. Rep. 49 1-8.
392. W.M. Valenti, P.H. Pincus and M.K. Messner (1980) Nosocomial pertussis: Possible spread by a hospital visitor. Am. J. Dis. Child. 134 520-521.
393. P.G. Van Buynder, D. Owen, J.E. Vurdien, et al. (1999) Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol. Infect. 123 403-411.
394. M. Vancanneyt, P. Vandamme and K. Kersters (1995) Differentiation of Bordetella pertussis B. parapertussis, and B. bronchiseptica by whole-cell protein electrophoresis and fatty acid analysis. Int. J. Syst. Bacteriol. 45 843-847.
395. P. Vandamme, M. Heyndrickx, M. Vancanneyt, et al. (1996) Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Rüger and Tan 1983. Int. J. Syst. Bacteriol. 46 849-858.
396. A. van der Zee, C. Agterberg, M. Peeters, et al. (1993) Polymerase chain reaction assay for pertussis: Simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J. Clin. Microbiol. 31 2134-2140.
397. A. van der Zee, C. Agterberg, M. Peeters, et al. (1996) A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: Comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J. Infect. Dis. 174 89-96.
398. A.M. Van Kruijssen, K.E. Templeton, R.N. van der Plas, et al. (2007) Detection of respiratory pathogens by real-time PCR in children with clinical suspicion of pertussis. Eur. J. Pediatr. 166 1189-1191.
399. F.G.A. Versteegh, J.F.P. Schellekens, A.F. Nagelkerke, et al. (2002) Laboratory-confirmed reinfections with Bordetella pertussis. Acta Paediatr 91 95-99.
400. M.K. Viljanen, O. Ruuskanen, C. Granberg, et al. (1982) Serological diagnosis of pertussis: IgM, IgA, and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). Scand. J. Infect. Dis. 14 117-122.
401. J.M. Vincent, J.D. Cherry, W.F. Nauschuetz, et al. (2000) Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: A serological search for causation. Clin. Infect. Dis. 30 534-539.
402. C.R. Vitek, F.B. Pascual, A.L. Baughman, et al. (2003) Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr. Infect. Dis. J. 22 628-634.
403. F. Von Wintzingerode, A. Schattke, R.A. Siddiqui, et al. (2001) Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int. J. Syst. Evol. Microbiol. 51 1257-1265.
404. A.M. Walker, H. Jick, D.R. Perera, et al. (1988) Neurologic events following diphtheria-tetanus-pertussis immunization. Pediatrics 81 345-349.
405. K.E. Walker and A.A. Weiss (1994) Characterization of the dermonecrotic toxin in members of the genus Bordetella. Infect. Immun. 62 3817-3828.
406. J.I. Ward, J.D. Cherry, S. Chang, et al. (2005) Efficacy of an acellular pertussis vaccine among adolescents and adults. N. Engl. J. Med. 353 1555-1563.
407. J.I. Ward, J.D. Cherry, S. Chang, et al. (2006) Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized acellular pertussis vaccine trial (APERT). Clin. Infect. Dis. 43 151-157.
408. O. Wärngård, L. Nilsson, C. Fåhraeus, et al. (1998) Catch-up primary vaccination with acellular pertussis vaccines in 3-4-year-old children-reactogenicity and serological response. Vaccine 16 480-484.
409. T.C. Washburn, D.N. Medearis and B. Childs (1965) Sex differences in susceptibility to infection. Pediatrics 35 57-67.
410. E.C. Watts and C. Acosta (1969) Pertussis and bilateral subdural hematomas. Am. J. Dis. Child. 118 518-519.
411. A.A. Weiss and S. Falkow (1984) Genetic analysis of phase variation in Bordetella pertussis. Infect. Immun. 43 263-269.
412. A.A. Weiss and E.L. Hewlett (1986) Virulence factors of Bordetella pertussis. Annu. Rev. Microbiol. 40 661-686.
413. A.A. Weiss, E.L. Hewlett, G.A. Myers, et al. (1984) Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J. Infect. Dis. 2 219-222.
414. R.S. Weyant, D.G. Hollis, R.E. Weaver, et al. (1995) Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J. Clin. Microbiol. 33 1-7.
415. E.J.H. Wiertz, H.G. Loggen, H.D. Walvoort, et al. (1989) In vitro induction of antigen specific antibody synthesis and proliferation of T lymphocytes with acellular pertussis vaccines, pertussis toxin and filamentous hemagglutinin in humans. J. Biol. Stand. 17 181-190.
416. G.D. Williams, A. Numa, J. Sokol, et al. (1998) ECLS in pertussis: Does it have a role? Intensive Care Med. 24 1089-1092.
417. R.J.L. Willems, J. Kamerbeek, C.A.W. Geuijen, et al. (1998) The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. Vaccine 16 410-416.
418. G.S. Wilson (1967) The Hazards of Immunization London: Althone Press
419. C.H. Wirsing von König, D. Gounis, S. Laukamp, et al. (1999) Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur. J. Clin. Microbiol. Infect. Dis. 18 341-345.
420. C.H. Wirsing von König, S. Postels-Multani, H.L. Bock, et al. (1995) Pertussis in adults: Frequency of transmission after household exposure. Lancet 346 1326-1329.
421. C.H. Wirsing von König, H. Rott, H. Bogaerts, et al. (1998) A serologic study of organisms possibly associated with pertussis-like coughing. Pediatr. Infect. Dis. J. 17 645-649.
422. A.L. Woolf and H. Caplin (1956) Whooping cough encephalitis. Arch. Dis. Child. 3 87-91.
423. B.F. Woolfrey and J.A. Moody (1991) Human infections associated with Bordetella bronchiseptica. Clin. Microbiol. Rev. 4 243-255.
424. World Health Organization (1991) World Health Organization Meeting on Case Definition of Pertussis, Geneva, January 10-11, 1991, MIM/EPI/PERT/9.1 Geneva: World Health Organization
425. N. Wortis, P.M. Strebel, M. Wharton, et al. (1996) Pertussis deaths: Report of 23 cases in the United States, 1992 and 1993. Pediatrics 97 607-612.
426. S.W. Wright, K.M. Edwards, M.D. Decker, et al. (1995) Pertussis infections in adults with persistent cough. JAMA 273 1044-1046.
427. W.K. Yih, E.A. Silva, J. Ida, et al. (1999) Bordetella holmesii–like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg. Infect. Dis. 5 441-443.
428. M.H. Yuk, E.T. Harvill, J.F. Miller, et al. (1998) The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol. Microbiol. 28 945-959.
429. G. Zackrisson, T. Lagergard, B. Trollfors, et al. (1990) Immunoglobulin A antibodies to pertussis toxin and filamentous hemagglutinin in saliva from patients with pertussis. J. Clin. Microbiol. 28 1502-1505.
430. A. Zee, C. Agterberg, M. Peeters, et al. (1993) Polymerase chain reaction assay for pertussis: Simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J. Clin. Microbiol. 31 2134-2140.
431. F. Zepp, M. Knuf, P. Habermehl, et al. (1996) Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect. Immun. 64 4078-4084.
432. Y.L. Zhang and R.D. Sekura (1991) Purification and characterization of the heat-labile toxin of Bordetella pertussis. Infect. Immun. 59 3754-3759.
433. D. Zoumboulakis, D. Anagnostakis, V. Albams, et al. (1973) Steroids in treatment of pertussis: A controlled clinical trial. Arch. Dis. Child. 48 51-54.